Optus Pharmaceutical Co Ltd
KOSDAQ:131030
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Optus Pharmaceutical Co Ltd
Retained Earnings
Optus Pharmaceutical Co Ltd
Retained Earnings Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Retained Earnings | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
O
|
Optus Pharmaceutical Co Ltd
KOSDAQ:131030
|
Retained Earnings
₩115.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
18%
|
|
|
Suheung Co Ltd
KRX:008490
|
Retained Earnings
₩472.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
|
SD Biosensor Inc
KRX:137310
|
Retained Earnings
₩1.8T
|
CAGR 3-Years
2%
|
CAGR 5-Years
185%
|
CAGR 10-Years
N/A
|
|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Retained Earnings
₩79.6B
|
CAGR 3-Years
45%
|
CAGR 5-Years
69%
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Inc
KOSDAQ:028300
|
Retained Earnings
₩2.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-11%
|
|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Retained Earnings
₩140.3B
|
CAGR 3-Years
35%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
Optus Pharmaceutical Co Ltd
Glance View
OPTUS Pharmaceutical Co., Ltd. engages in the manufacture and sale of ophthalmic products. The company is headquartered in Cheongju, Chungcheongbuk-Do and currently employs 171 full-time employees. The company went IPO on 2010-12-03. The firm is primarily engaged in the manufacture and sale of eye drops and ophthalmic preparations such as dry eye treatment agents, conjunctivitis treatment agents, anti-inflammatory medication agents, glaucoma treatment agents and others.
See Also
What is Optus Pharmaceutical Co Ltd's Retained Earnings?
Retained Earnings
115.7B
KRW
Based on the financial report for Dec 31, 2025, Optus Pharmaceutical Co Ltd's Retained Earnings amounts to 115.7B KRW.
What is Optus Pharmaceutical Co Ltd's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
18%
Over the last year, the Retained Earnings growth was 11%. The average annual Retained Earnings growth rates for Optus Pharmaceutical Co Ltd have been 10% over the past three years , 8% over the past five years , and 18% over the past ten years .
